End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
40.86 EUR | -1.49% | 0.00% | +2.97% |
06-26 | Demant Flags Delay in Completion of Communications Business' Strategic Review | MT |
05-29 | UK’s Competition Regulator Closes Cochlear-Demant Deal | MT |
Chart calendar Demant A/S
Upcoming events on Demant A/S
Past events on Demant A/S
2024-06-17 | Citi European Healthcare Conference |
2024-06-11 | Danske Bank Hearing Aid Seminar |
2024-05-22 | Roadshow - SEB |
2024-05-21 | Deutsche Bank Conference |
2024-05-07 | Roadshow - Barclays |
2024-05-06 06:00 | Q1 2024 Sales and Revenue Call - Interim Management Statement |
2024-05-06 01:28 | Q1 2024 Sales and Revenue Release - Interim Management Statement |
2024-04-17 | Roadshow - Citi |
2024-04-16 | Roadshow |
2024-04-15 | Roadshow - Citi |
2024-04-10 | Roadshow - Danske Bank |
2024-03-20 | Roadshow - Bank of America |
2024-03-19 | Roadshow - Mirabaud - Day 2 |
2024-03-18 | Roadshow - Mirabaud - Day 1 |
2024-03-12 06:00 | Capital Markets Day |
2024-03-05 | Annual General Meeting |
2024-02-26 | Morgan Stanley European MedTech and Life Sciences Conference |
2024-02-26 | UBS European Healthcare Conference |
2024-02-22 | Roadshow - Demant |
2024-02-21 | Roadshow - Demant |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million DKK | Released Forecast Spread | 14 946 14 792 1.04% | 14 469 14 445 0.16% | 18 388 18 524 -0.74% | 19 705 19 594 0.57% | 22 443 22 418 0.11% | 23 229 |
EBITDA Million DKK | Released Forecast Spread | 3 110 3 084 0.85% | 2 578 2 307 11.77% | 4 536 4 462 1.67% | 4 383 4 407 -0.55% | 5 482 5 408 1.36% | 6 140 |
EBIT Million DKK | Released Forecast Spread | 2 151 2 160 -0.4% | 1 313 1 389 -5.48% | 3 386 3 415 -0.85% | 3 207 3 313 -3.2% | 4 148 4 164 -0.38% | 4 771 |
Earnings before Tax (EBT) Million DKK | Released Forecast Spread | 1 911 1 947 -1.87% | 1 336 1 237 7.97% | 3 243 3 243 0.01% | 2 927 3 144 -6.89% | 3 394 3 433 -1.14% | 4 041 |
Net income Million DKK | Released Forecast Spread | 1 462 1 504 -2.78% | 1 121 1 046 7.18% | 2 513 2 503 0.39% | 2 082 2 254 -7.61% | 1 795 1 859 -3.43% | 3 038 |
EPS DKK | Released Forecast Spread | 6,00 6,18 -2.88% | 4,68 4,37 7.2% | 10,7 10,7 0.2% | 9,21 10,1 -8.64% | 8,04 8,30 -3.19% | 14,0 |
Announcement Date | 04/02/20 | 09/02/21 | 08/02/22 | 07/02/23 | 05/02/24 | - |
Quarterly results
Fiscal Period | December | 2019 S2 | 2020 S1 | 2020 S2 | 2021 S1 | 2021 S2 | 2022 Q2 | 2022 S1 | 2022 Q4 | 2022 S2 | 2023 Q1 | 2023 Q2 | 2023 S1 | 2023 Q3 | 2023 Q4 | 2023 S2 | 2024 Q1 | 2024 Q2 | 2024 S1 | 2024 Q3 | 2024 Q4 | 2024 S2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million DKK | Released Forecast Spread | 7 596 7 464 1.77% | 6 078 5 789 5% | 8 391 8 385 0.08% | 9 012 8 838 1.97% | 9 376 9 554 -1.86% | 4 894 4 965 -1.43% | 9 497 9 630 -1.38% | 5 345 5 070 5.43% | 10 208 10 106 1.01% | 5 508 | 5 647 5 627 0.36% | 11 155 10 858 2.74% | 5 403 5 441 -0.7% | 5 885 5 865 0.34% | 11 288 11 268 0.18% | 5 575 | 5 851 | 11 347 | 5 687 | 6 192 | 11 959 |
EBITDA Million DKK | Released Forecast Spread | 1 528 1 590 -3.87% | 629 492 27.85% | 1 949 1 952 -0.13% | 2 162 2 103 2.79% | 2 374 2 399 -1.03% | 893 | 2 128 2 249 -5.38% | 2 255 2 289 -1.49% | 2 662 2 784 -4.38% | 2 820 2 806 0.5% | |||||||||||
EBIT Million DKK | Released Forecast Spread | 1 038 1 058 -1.87% | -193 -93,1 -107.25% | 1 506 1 456 3.44% | 1 638 1 581 3.63% | 1 748 1 814 -3.65% | 1 588 1 724 -7.88% | 1 619 1 696 -4.54% | 2 014 2 073 -2.83% | 2 134 2 159 -1.14% | 2 196 | 2 572 | ||||||||||
Earnings before Tax (EBT) Million DKK | Released Forecast Spread | 917 949 -3.37% | 26,0 -18,8 238.05% | 1 310 1 317 -0.52% | 1 536 1 501 2.33% | 1 707 1 768 -3.42% | 1 493 1 565 -4.6% | 1 434 1 533 -6.46% | 1 655 1 813 -8.69% | 1 739 1 780 -2.3% | 1 900 | 2 161 | ||||||||||
Net income Million DKK | Released Forecast Spread | 699 741 -5.6% | 119 28,1 322.84% | 1 013 1 035 -2.11% | 1 174 1 120 4.82% | 1 339 1 357 -1.31% | 1 049 1 251 -16.11% | 1 033 1 115 -7.35% | 581 755 -23.05% | 1 214 930 30.54% | ||||||||||||
EPS DKK | Released Forecast Spread | 2,88 3,07 -6.11% | 0,50 0,12 325.53% | 4,18 4,44 -5.86% | 4,94 4,74 4.19% | 5,76 5,70 1.14% | 4,60 5,14 -10.45% | 4,61 4,72 -2.33% | 5,44 5,92 -8.11% | |||||||||||||
Announcement Date | 04/02/20 | 17/08/20 | 09/02/21 | 12/08/21 | 08/02/22 | 16/08/22 | 16/08/22 | 07/02/23 | 07/02/23 | - | 15/08/23 | 15/08/23 | 07/11/23 | 05/02/24 | 05/02/24 | - | - | - | - | - | - |
Past sector events for Demant A/S
2024-05-14 01:00 | SONOVA HOLDING AG: Q4 2024 Earnings Release |
2024-05-06 01:28 | DEMANT A/S: Q1 2024 Sales and Revenue Release - Interim Management Statement |
2024-04-30 01:00 | STRAUMANN HOLDING AG: Q1 2024 Earnings Release |
2024-04-23 01:00 | EMBLA MEDICAL HF.: Q1 2024 Earnings Release |
2024-04-17 | EYEBRIGHT MEDICAL TECHNOLOGY (BEIJING) CO., LTD.: Q1 2024 Earnings Release |
2024-04-17 | EYEBRIGHT MEDICAL TECHNOLOGY (BEIJING) CO., LTD.: Q4 2023 Earnings Release |
2024-03-18 | ANGELALIGN TECHNOLOGY INC.: Q4 2023 Earnings Release |
2024-02-27 01:00 | STRAUMANN HOLDING AG: Q4 2023 Earnings Release |
2024-02-18 15:30 | COCHLEAR LIMITED: Q2 2024 Earnings Release |
2024-02-05 11:45 | DEMANT A/S: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- DEMANT Stock
- DEMA Stock
- Calendar Demant A/S